Papers

2

Total Citations

23

H-Index

2

About

Francesco Cattafi is a leading figure in robotic urologic oncology, with a specialized focus on optimizing surgical outcomes for bladder cancer patients. His research centers on robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion, particularly the orthotopic neobladder. Cattafi’s major contribution lies in systematically applying standardized, evidence-based protocols to collect and report complications, as demonstrated in his highly cited 2024 work on peri- and post-operative outcomes after RARC at a high-volume referral center (19 citations). This study, aligned with EAU guidelines, provides a rigorous framework for benchmarking surgical quality. Additionally, his investigation into long-term functional outcomes after RARC with intracorporeal ileal orthotopic neobladder (4 citations) offers critical insights into patient recovery, detailing daily pad usage and clean intermittent catheterization rates over follow-up. By combining meticulous complication tracking with detailed functional data, Cattafi advances the field toward more transparent, patient-centered reporting. His work is essential reading for surgeons and researchers aiming to improve both the safety and quality of life after radical cystectomy.

Research Focus

Key Achievements

2
H-Index
2
Papers
23
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center
19 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico, IRCCS Ospedale San Raffaele

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago